Comparing 24-Hour Versus 7-Day Antibiotic Use After Major Head and Neck Cancer Surgery to Prevent Wound Infection
Led by AC Camargo Cancer Center · Updated on 2026-10-05
80
Participants Needed
1
Research Sites
152 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying adults undergoing major surgery for mouth or throat cancer to see if giving antibiotics for 7 days after surgery reduces the chance of surgical wound infections compared to the usual 24-hour antibiotic course. The study focuses on surgeries that may include tissue reconstruction from another body part and aims to determine if the longer antibiotic course is safer, lowers infections, shortens hospital stays, and reduces emergency visits and readmissions.
Participants receive the antibiotic ampicillinsulbactam through a vein before and during surgery. After surgery, one group continues the antibiotic for 24 hours, the current standard, while the other group continues it for 7 days or until they leave the hospital if sooner. Both groups follow a 5-day preoperative care routine involving mouthwash, antiseptic body wash, and nasal ointment. The trial is randomized and open-label, with patients assigned by chance to either group.
During the 30 days after surgery, participants are monitored for surgical wound infections and other complications. Researchers collect detailed information including demographics, lifestyle, tumor details, surgical data, and hospital costs. Safety is closely watched, including adverse effects like other infections or allergic reactions. The study aims to enroll 80 patients and will analyze data to compare infection rates and hospital outcomes between the two antibiotic durations.
CONDITIONS
Brief Title
Prophylactic Antibiotic Duration in Head and Neck Cancer Surgery (PROTECT-HN Trial)
Research Team
G
Genival Barbosa de Carvalho, PhD
R
Renata Otoni Neiva, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosed with cancer of the oral cavity or pharynx
Scheduled for major head and neck surgery and/or reconstruction with a microvascular free flap or pedicled flap
Surgery involves communication between the primary tumor site and the neck
Signed informed consent
You will not qualify if you...
Known allergy to ampicillin/sulbactam, penicillins, or other beta-lactam antibiotics
Surgical field infected or active infection requiring therapeutic antibiotics at surgery time
Refusal to participate
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit
Preoperative Care
Duration - 5 days
Participants complete a 5-day preoperative decolonization routine including chlorhexidine oral rinse, body wash, and nasal ointment. They also have consultations for nursing, nutrition, and oral medicine.
Daily routine care
Surgery and Antibiotic Treatment
Duration - Up to 7 days or until hospital discharge
Participants receive intravenous ampicillin/sulbactam before and during surgery. After surgery, they receive either 24 hours or 7 days of antibiotic treatment depending on their group.
Antibiotics given during surgery and postoperatively as per group assignment
Postoperative Follow-up
Duration - 30 days
Participants are followed for 30 days after surgery to monitor for surgical wound infection, complications, emergency visits, readmissions, and safety events.
Regular monitoring and assessments
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Evaluating Safety and Tolerability of Amicidin- Topical Solution for Adults with Contaminated or Infected Surgical and Traumatic Wounds or Cutaneous Abscesses
Reduced Radiation and Chemotherapy Followed by Planned Neck Dissection Surgery for Head and Neck Cancer Patients Without Tumor Hypoxia
Phase II Study of Pembrolizumab Combined With Tumor DNA-Guided Chemotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Study of Antibiotic Penetration and Tissue Response in Head and Neck Surgery and Infection Using Microdialysis
Collection and Study of Tissue Samples for Head and Neck Disorders to Support Research
Comparing Cosmetic Scars Using Scalpel, Electrocautery, and PEAK PlasmaBlade in Total Mastectomy Surgery Without Immediate Reconstruction
Phase I Trial of Zanzalintinib with Pembrolizumab and Cetuximab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Study of DPYD Gene Testing to Guide Fluoropyrimidine Chemotherapy Dosing
in Adults with Various Cancers
Study of Expiratory Muscle Strength Training to Improve Swallowing in Adults Receiving Radiation Therapy for Head and Neck Cancer
Testing a Decision-Support Program to Help Patients with Throat Cancer Decide on Clinical Trial Participation